To discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.
To our patients and customers, employees, global communities, shareholders, environment and other stakeholders, we promise to act on our belief that the priceless ingredient of every medicine is the integrity of its maker. We operate with effective governance and high standards of ethical behaviour. We seek transparency and dialogue with our stakeholders to improve our understanding of their needs. We take our commitment to economic, social, and environmental sustainability seriously, and extend this expectation to our partners and suppliers.
To our patients and customers
We commit to scientific excellence and investment in biopharmaceutical research and development to provide innovative, high-quality medicines that address the unmet medical needs of patients with serious diseases. We apply scientific rigour to produce clinical and economic benefit through medicines that improve patients’ lives. We strive to make information about our commercialisised medicines widely and readily available.
To our employees
We embrace a diverse workforce and inclusive culture. The health, safety, professional development, work-life balance, and equitable, respectful treatment of our employees are among our highest priorities.
To our global communities
We promote conscientious citizenship that improves health and promotes sustainability in our communities.
To our shareholders
We strive to produce sustained strong performance and shareholder value.
To our environment
We encourage the preservation of natural resources and strive to minimise the environmental impact of our operations and medicines.
Date of preparation: May 2018; MLTUK1701479-01